TIGIT and neoplasm: Given that TIGIT is highly expressed on activated, tumor-infiltrating NK cells and at lower levels on resting non-activated NK cells (Figure 1 and Figure 7), Fc-competent anti-TIGIT antibodies could lead to the depletion of this critical population through FcR-dependent mechanisms.